Second-generation tyrosine kinase inhibitors in chronic myelogenous leukemia

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations

Fingerprint Dive into the research topics of 'Second-generation tyrosine kinase inhibitors in chronic myelogenous leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences